Pharmaceutical - Anti-virals, Pharmaceutical

Filter

Current filters:

Anti-viralsPharmaceutical

Popular Filters

1 to 25 of 312 results

EMA advises GlaxoSmithKline on Ebola vaccine development

29-10-2014

The European Medicines Agency has given scientific advice to UK pharma major GlaxoSmithKline on its development…

Anti-viralsGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Vaxart accelerates development of Ebola tablet vaccine

24-10-2014

Privately-held US vaccine developer Vaxart says it is accelerating its Ebola tablet vaccine program.…

Anti-viralsPharmaceuticalResearchVaccinesVaxart

EMA moves further to push Ebola treatments development

EMA moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

Tekmira starts manufacture of new RNAi therapeutic for Ebola

Tekmira starts manufacture of new RNAi therapeutic for Ebola

22-10-2014

Canadian RNA interference (RNAi) therapeutics developer Tekmira Pharmaceuticals says it has commenced…

Anti-viralsCanadaPharmaceuticalProductionResearchTekmira PharmaceuticalsTKM-Ebola

EMA urging firms with Ebola candidates to seek orphan status

21-10-2014

The European Medicines Agency is aiming to encourage developers of treatments or vaccines against Ebola…

Anti-viralsEuropePharmaceuticalRare diseasesRegulationResearchUSA

Fujifilm starts production of Avigan for the treatment of Ebola

21-10-2014

Japan’s Fujifilm says it has decided to start production of the anti-influenza drug Avigan (favipiravir)…

Anti-viralsAviganFujifilmPharmaceuticalProductionResearchToyama

GSK Ebola vaccine “too late” for current Ebola outbreak; more on Ebola

17-10-2014

UK pharma giant GlaxoSmithKline says any Ebola vaccine it produces will come too late for the current…

Anti-viralsAVI-6002GlaxoSmithKlinePharmaceuticalProductionResearchSarepta Therapeutics

Public-private partnerships vital to advance Ebola treatment pipeline, says analyst

16-10-2014

In the battle against Ebola, incentives from governments and health care policymakers have been and will…

Anti-viralscAd3-ZEBOVGlaxoSmithKlineJohnson & JohnsonMapp BiopharmaceuticalNewLink GeneticsPharmaceuticalResearch

Bristol-Myers resolves Sustiva patent litigation in USA

Bristol-Myers resolves Sustiva patent litigation in USA

08-10-2014

US pharma major Bristol-Myers Squibb has successfully resolved all outstanding US patent litigation relating…

Anti-viralsAtriplaBristol-Myers SquibbCiplaLegalMerck & CoPatentsPharmaceuticalSustivaUSA

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

08-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president…

Anti-viralsBoardroomJapanPharmaceuticalTakeda Pharmaceutical

Novartis returns rights to Enanta’s NS5A Inhibitor EDP-239 for hep C

01-10-2014

USA-based discovery and development company Enanta Pharmaceuticals says it has entered into an agreement…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

IMS Health identifies 10 events that may transform the delivery of health care

IMS Health identifies 10 events that may transform the delivery of health care

23-09-2014

As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalRegulationResearchVaccines

Mitsubishi Tanabe Pharma gains approval for Telavic in genotype 2 HCV

Mitsubishi Tanabe Pharma gains approval for Telavic in genotype 2 HCV

22-09-2014

Japanese pharma company Mitsubishi Tanabe Pharma has received approval for an additional indication of…

Anti-viralsJapanMitsubishi TanabePharmaceuticalRegulationTelavic

UK NICE consults on draft guidance for hepatitis C drug Olysio

UK NICE consults on draft guidance for hepatitis C drug Olysio

18-09-2014

In draft guidance published today UK drugs watchdog the National Institute for Health and Care Excellence…

Anti-viralsJanssenJohnson & JohnsonOlysioPharmaceuticalPricingRegulationUK

Added benefit for certain patients found by IQWiG with Janssen’s Olysio

Added benefit for certain patients found by IQWiG with Janssen’s Olysio

15-09-2014

In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products…

Anti-viralsGermanyJanssenJohnson & JohnsonOlysioPharmaceuticalPricingRegulation

US Pharma now developing 44 drugs/vaccines for HIV/AIDS

11-09-2014

The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for…

Anti-viralsPharmaceuticalResearchUSAVaccines

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

03-09-2014

The European Commission has granted marketing authorization for ViiV Healthcare’s Triumeq (dolutegravir…

Anti-viralsEuropeGlaxoSmithKlinePharmaceuticalRegulationTriumeqViiV Healthcare

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

03-09-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has achieved its primary endpoint…

Anti-viralsDengueDengue feverPharmaceuticalSanofi PasteurSouth AmericaTropical diseases

Daiichi Sankyo links with Kaketsuken for Bimmugen sales

28-08-2014

Japanese drug major Daiichi Sankyo has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic…

Anti-viralsBimmugenDaiichi SankyoJapanKaketsukenLicensingMarkets & MarketingPharmaceuticalVaccines

1 to 25 of 312 results

Parexel

Parexel

Back to top